Risks of adjuvant whole brain radiation therapy outweigh benefits for patients with limited brain metastases

Bookmark and Share
Published: 31 May 2015
Views: 1715
Rating:
Save
Dr Jan Buckner - Mayo Clinic, Rochester, USA

Dr Buckner presents, at a press conference at ASCO 2015,  a federally funded phase III trial that is providing additional information regarding a long-standing discussion about the impact of adjuvant whole brain radiation therapy (WBRT) on cognitive function.

Read the news article and watch the video interview for more.